Zobrazeno 1 - 10
of 24
pro vyhledávání: '"I-Heng Lee"'
Autor:
Jeffrey R. Curtis, Robert R. McLean, I‐Heng Lee, Rachel H. Mackey, Page C. Moore, Richard Haubrich, Jeffrey D. Greenberg, Alicea Wu
Publikováno v:
ACR Open Rheumatology, Vol 6, Iss 5, Pp 253-264 (2024)
Objective To describe and identify associated factors for patient–clinician discordance of disease assessment at biologic or Janus kinase inhibitor (JAKi) initiation and over 12 months following initiation in patients with rheumatoid arthritis (RA)
Externí odkaz:
https://doaj.org/article/6c378415e1284b08b0037905b3d6a940
Autor:
Maria Julieta Germar, Carrie Purugganan, Ma. Socorro Bernardino, Benjamin Cuenca, Y-Chen Chen, Xiao Li, Georges Van Kriekinge, I-Heng Lee
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 13, Iss 5, Pp 1158-1166 (2017)
Cervical cancer (CC) is the second leading cause of cancer death among Filipino women. Human papillomavirus (HPV) vaccination protects against CC. Two vaccines (AS04-HPV-16/18 and 4vHPV) are approved in the Philippines; they were originally developed
Externí odkaz:
https://doaj.org/article/59d1cb7b633242048a281d7145173d12
Publikováno v:
JGH Open, Vol 4, Iss 5, Pp 808-817 (2020)
Abstract Non‐alcoholic fatty liver disease (NAFLD) and non‐alcoholic steatohepatitis (NASH) represent a growing unmet medical need and an increasingly prevalent cause of cirrhosis, hepatocellular carcinoma (HCC), and death in Japan. The aim of th
Externí odkaz:
https://doaj.org/article/3acb22c2bb794cb1bee22f0c33809c20
Autor:
Sunil Majethia, Scott Bunner, Alice Hsiao, John Wolf, Ben Chastek, Essy Mozaffari, I-Heng Lee
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 28:48-57
BACKGROUND: The American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA) recommended in May 2019 that patients with hepatitis C virus (HCV)...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae8f347b62079f19d01265ae4ddc3acb
https://doi.org/10.18553/jmcp.2021.21246
https://doi.org/10.18553/jmcp.2021.21246
Publikováno v:
Journal of Gastroenterology
Background This study examined demographics, comorbidities and healthcare resource use (HCRU) and costs among Japanese patients with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). Methods We conducted a repeated cro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1d8435fd8a3227281876a55b4480e26
https://doi.org/10.1007/s00535-021-01759-2
https://doi.org/10.1007/s00535-021-01759-2
Publikováno v:
Hepatology Research. 51:19-30
AIMS Hepatocellular carcinoma (HCC) is a significant cause of morbidity and mortality in Japan. As the treatment of viral hepatitis improves, non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are rapidly becoming lead
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dff37c95566ae897fb68e95dd4864a42
https://doi.org/10.1111/hepr.13583
https://doi.org/10.1111/hepr.13583
Autor:
Hyun Jung Ahn, Sungeun Jung, Bo Ok Kim, Mindie H. Nguyen, Hyunwoo Oh, Dae Won Jun, I-Heng Lee
Publikováno v:
Alimentary Pharmacology & Therapeutics. 52:371-381
BACKGROUND It is controversial whether chronic hepatitis B (CHB) patients have more non-liver comorbidities than non-CHB subjects. AIM To characterise the demographics, comorbidity and health utilisation of CHB patients in South Korea and compare the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea1495d925c31c8ca8603871a64542f7
https://doi.org/10.1111/apt.15867
https://doi.org/10.1111/apt.15867
Publikováno v:
World Journal of Hepatology
About 10 million people in China are infected with hepatitis C virus (HCV), with the seroprevalence of anti-HCV in the general population estimated at 0.6%. Delaying effective treatment of chronic hepatitis C (CHC) is associated with liver disease pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29ef07dcc3828f32c065148bec5b75e4
http://europepmc.org/articles/PMC6547290
http://europepmc.org/articles/PMC6547290
Autor:
Woo Yun Sohn, Soo Young Hur, I-Heng Lee, Byoung Gie Kim, Hyunju Lee, Georges Van Kriekinge, Hyeongap Jang
Publikováno v:
Asian Pacific Journal of Cancer Prevention : APJCP
Background: Cervical cancer is caused by the human papillomavirus and is a leading cause of cancer death among young Korean women. Current screening programmes could benefit from the addition of HPV vaccination into their schedule to help reduce dise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78d3b773abf5e7df206b2d6f91fbb1f3
http://europepmc.org/articles/PMC6897004
http://europepmc.org/articles/PMC6897004
Autor:
Jinlin Hou, Fengqin Hou, Wendong Chen, Xueru Yin, I-Heng Lee, Ling-I Hsu, Ying Han, Lei Wang, Dongying Xie, Yida Yang
Publikováno v:
Journal of comparative effectiveness research. 10(8)
Chronic hepatitis B demographics and comorbidity data are limited in China. Materials & methods: The China Health Insurance Association claims database from 2013 and 2016 was used to augment the existing data: the proportion of patients aged >45 year
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4f43245d7d9635d8b2216200e7d0050
https://pubmed.ncbi.nlm.nih.gov/33970683
https://pubmed.ncbi.nlm.nih.gov/33970683